Swift Biosciences myT Primer reagents are designed for the detection of key cancer mutations.
The primers provide an increased level of confidence and convenience in qPCR
assays. The reagents have unique structural and thermodynamic properties
that enable highly sensitive mismatch discrimination. The extreme
selectivity and reproducibility of these primers results in an assay that
gives a definitive answer and eliminates the need to use a delta Ct method
to call a result. myT BRAF, the first product in the myT Primer line, is
designed to detect 1% mutant BRAF V600E/K present in a background of 103
wild-type genomic DNA copies with no breakthrough amplification from
wild-type. myT BRAF performs well with either FFPE or fresh frozen samples.
Each myT BRAF package includes sufficient reagents to assess up to 28
samples plus a positive and a negative control.